Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
02/2009
02/12/2009WO2009019286A1 Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
02/12/2009WO2009018657A1 Viral polymerase inhibitors
02/12/2009WO2009018656A1 Viral polymerase inhibitors
02/12/2009WO2008155421A3 Indolin-2-ones and aza-indolin-2-ones
02/12/2009WO2008139481A3 Proton acceptor iminium/carbocation-type coupling agents
02/12/2009WO2008008539A3 Fused heterocyclic derivatives useful as inhibitors of the hepatocyte growth factor receptor
02/12/2009US20090043100 Process for Producing Optically Active Chromene Oxide Compound
02/12/2009US20090042931 Tricyclic Angiotensin II Agonists
02/12/2009US20090042928 Modulators of muscarinic receptors
02/12/2009US20090042927 Salts, Prodrugs and Polymorphs of Fab I Inhibitors
02/12/2009US20090042926 Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment
02/12/2009US20090042925 Oxime substituted imidazoquinolines
02/12/2009US20090042924 1,6-dimethyl-3-(pyridin-4-yl)-1,9-dihydro-2H-pyrido[2,3-b]indol-2-one, used as anticarcinogenic or antitumor agents
02/12/2009US20090042921 Spiroindoline derivatives having insecticidal properties
02/12/2009US20090042920 Carbonylamino-derivatives as novel inhibitors of histone deacetylase
02/12/2009US20090042891 6-(3-Fluorophenyl)-5-pyridin-4-ylpyrazin-2-amine, used in the treatment of asthma, chronic obstructive pulmonary disorder, fibrosis, emphysema, allergies, inflammation, reperfusion injury, ischemia, atherosclerosis, hypertension, retinopathy, diabetes, inflammatory bowel disease or autoimmune diseases
02/12/2009US20090042880 Novel 4-benzimidazol-2-ylpyridazin-3-one derivatives
02/12/2009US20090042876 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors
02/12/2009US20090042873 Tricyclic n-heteroaryl-carboxamide derivatives containing a benzimidazole unit, method for preparing same and their therapeutic use
02/12/2009US20090042871 delta-opioid receptor agonists as analgesics having reduced side effects and antagonists as immunosuppressants, antiinflammatory agents, neurological, psychiatric , urological and reproductive conditions; N-{2-[10-(8-Allyl-8-aza-bicyclo[3.2.1]oct-3-yl)-10H-phenothiazine-3-yl]-phenyl}-acetamide
02/12/2009US20090042859 Spiro-condensed indoline derivatives as pesticides
02/12/2009US20090042856 Pyridazinone derivatives used for the treatment of pain
02/12/2009US20090042061 Electron transporting materials and organic light-emitting devices therewith
02/12/2009CA2707030A1 Imidazopyridinones
02/12/2009CA2699461A1 Inhibitors of intracellular urokinase plasminogen activator and methods of use thereof
02/12/2009CA2694297A1 Silicon derivatives as histone deacetylase inhibitors
02/12/2009CA2693997A1 Viral polymerase inhibitors
02/12/2009CA2693495A1 Viral polymerase inhibitors
02/12/2009CA2691529A1 Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
02/11/2009EP2022793A1 Novel heterocyclic compound or salt thereof and intermediate thereof
02/11/2009EP2022792A1 Novel compound having affinity to amyloid
02/11/2009EP2021343A1 Imidazoazephinone compounds
02/11/2009EP2021342A1 PYRIDO[3,2-e]PYRAZINES, THEIR USE AS INHIBITORS OF PHOSPHODIESTERASE 10, AND PROCESSES FOR PREPARING THEM
02/11/2009EP2021341A1 4-AMINO-PYRIDOÝ3,2-e¨PYRAZINES, THEIR USE AS INHIBITORS OF PHOSPHODIESTERASE 10, AND PROCESSES FOR PREPARING THEM
02/11/2009EP2021340A2 Beta-amyloid pet imaging agents
02/11/2009EP2021331A1 2-phenyl-5-amino-1,3,4-oxadiazoles and their use as nicotinic acetylcholine receptor ligands
02/11/2009EP2021004A2 Substituted azaspiro derivatives
02/11/2009EP1853601B1 Non steroidal glucocorticoid receptor modulators
02/11/2009EP1851217B1 Substituted pyrido[2,3-d]pyrimidine derivatives useful as medicines for the treatment of autoimmune disorders
02/11/2009EP1605938B1 Antibacterial derivatives of napthydrin and quinoline
02/11/2009CN101365757A Naphthalene amidine imides
02/11/2009CN101365708A Crystalline forms of 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1h-1,2,4-triazol-1-yl)-1-[(phosphonooxy)methyl]-1h-pyrrolo[2,3-c]pyridin-3-yl]-1,2-dioxoethyl]-piperazine
02/11/2009CN101365700A Azaindazoles useful as inhibitors of kinases
02/11/2009CN101365699A Pyrido(3,2-D)pyrimidines and pharmaceutical compositions useful for medical treatment
02/11/2009CN101365680A 3,5-substituted piperidine compounds as renin inhibitors
02/11/2009CN101365446A Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices
02/11/2009CN101362755A Sulfosulfuron preparation method
02/11/2009CN101362719A Chinolines derivates and composition containing thereof
02/10/2009US7488826 Substituted pyrroline kinase inhibitors
02/10/2009US7488740 Substituted quinolin-4-ylamine analogues
02/10/2009US7488737 Each compound having an azabicyclic ring attached via a ring N or amino group; neuroprotectants; neurodegenerative diseases, analgesics, psychological disorders; e.g. 5-Methoxy-N-(8-methyl-8-azabicyclo[3.2.1]oct-3-yl)-1H-indazole-3-carboxamide; ligands for nicotinic acetylcholine receptors
02/10/2009US7488736 serotonin receptor agonist and antagonist; antidepressant, anxoilytic agent, neurodegenerative diseases; neurodegenerative disease, cognition disorders, irritable bowel syndrome, nausea; 6,7-Dihydro-4-hydroxy-7-isopropyl-6-oxo-N-(3-(piperidin-1-yl)propyl)thieno[2,3-b]pyridine-5-carboxamid potassium salt
02/10/2009US7488494 Competitive binding to estrogen; prevent mnopause syndrome ; anxiolytic agents; antidepressants; benign prostatic hyperplasia; anticancer agents; inflammatory bowel disorders; antiarthritic agents
02/10/2009CA2211270C Novel cycloalkyl derivatives as inhibitors of bone resorption and vitronectin receptor antagonists
02/05/2009WO2009018466A1 Naphthyridine derivatives as potassium channel modulators
02/05/2009WO2009018415A1 Process for preparing 5-fluoro-1h-pyrazolo [3, 4-b] pyridin-3-amine and derivatives thereof
02/05/2009WO2009018065A2 Novel glucokinase activators and methods of using same
02/05/2009WO2009017795A1 Indazole compounds for treating inflammatory disorders, demyelinating disorders and cancers
02/05/2009WO2009017236A1 Pyridopyrimidin-4-one derivatives
02/05/2009WO2009016841A1 Oxopyrazine derivative and herbicide
02/05/2009WO2009016653A1 Stable polymorphic form of paliperidone and process for its preparation
02/05/2009WO2009016460A2 Pyrazole compounds and their use as raf inhibitors
02/05/2009WO2009015897A1 Novel heterocyclic compounds as mglu5 antagonists
02/05/2009WO2009015828A1 Paliperidone derivatives
02/05/2009WO2008129054A3 Heterocyclic compounds with affinity to muscarinic receptors
02/05/2009WO2008122534A3 Non-nucleoside reverse transcriptase inhibitors
02/05/2009WO2008047951A3 An alzheimer' s disease progression inhibitor containing heterocyclic compound
02/05/2009US20090036673 Ecteinascidin 743; 5-(1,2-diaminoethyl-), 3,4-methylenedioxyphenol intermediate, of which the amine group cyclizes
02/05/2009US20090036482 Imidazopyridine-derivatives as inductible no-synthase inhibitors
02/05/2009US20090036481 Novel Azaindole Inhibitors of Mtp and Apob
02/05/2009US20090036457 Utilities of olefin derivatives
02/05/2009US20090036445 Kinase inhibitors
02/05/2009US20090036442 N-aroyl cyclic amine derivatives as orexin receptor antagonists
02/05/2009US20090036434 Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
02/05/2009US20090036433 Heterocyclic Compounds, their Preparation and their Use as Antibacterials
02/05/2009US20090036430 Pyrido(3,2-d)pyrimidines and pharmaceutical compositions useful for medical treatment
02/05/2009US20090036427 Substituted bicyclic pyrimidone derivatives
02/05/2009US20090036422 Monoamide derivatives as orexin receptor antagonists
02/05/2009US20090035810 Modified carbocyanine dyes and their conjugates
02/05/2009US20090035809 Modified Carbocyanine Dyes and Their Conjugates
02/05/2009US20090035313 Compounds
02/05/2009CA2695196A1 Naphthyridine derivatives as potassium channel modulators
02/05/2009CA2695114A1 Pyrazole compounds and their use as raf inhibitors
02/05/2009CA2694882A1 Oxopyrazine derivative and herbicide
02/05/2009CA2694499A1 Process for preparing 5-fluoro-1h-pyrazolo [3, 4-b] pyridin-3-amine and derivatives thereof
02/05/2009CA2694359A1 Novel heterocyclic compounds as mglu5 antagonists
02/04/2009EP2020411A1 Spiro tetracyclic compound
02/04/2009EP2020410A1 Pyrido[2,3d]pyrimidine derivatives, process for their preparation and their therapeutical use
02/04/2009EP2019677A2 Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
02/04/2009EP1824817B1 Arylsulfonylnaphthalene derivatives as 5ht2a antagonists
02/04/2009EP1733161A4 Device and method for pneumatic valve control
02/04/2009CN101360745A 8-azabicyclo[3.2.1]octane derivatives useful as monoamine reuptake inhibitors
02/04/2009CN101357915A Diazabicyclic central nervous system active agents
02/04/2009CN101357914A Lactam-containing compounds and derivatives thereof as factor xa inhibitors
02/04/2009CN100457757C Novel spiro compounds
02/04/2009CN100457755C Sulfonic derivative, lyotropic liquid crystal system and anisotropic membrane containing same
02/04/2009CN100457754C Substituted indolepyridinium as anti-infective compounds
02/04/2009CN100457729C 2,4-dihalogen-6-(c2-c3-alkyl)-phenyl substituted tetramic acid derivatives
02/04/2009CN100457726C Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obestity and type II diabetes
02/03/2009US7485654 Corneal perception recovery drug containing amide compound